Literature DB >> 34370552

Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis.

Yihong Huang1, Shuo Zheng2, Ying Lin1, Liming Ke1.   

Abstract

Triple-negative breast cancer (TNBC) is an aggressive histological subtype of breast cancer. It has been reported that the circular RNA (circRNA) circ-ERBB2 (circBase identifier hsa_circ_0007766) is mainly distributed in the cytoplasm of TNBC cells and promotes the proliferation and invasion of TNBC cells. This study aimed to explore the molecular mechanism of circ-ERBB2 regulating the progression of TNBC. The expression of circ-ERBB2 was detected by quantitative real-time PCR (qRT-PCR). Loss-of-function experiments were performed to investigate the function of circ-ERBB2 in TNBC cells in vitro and in vivo. The regulatory mechanism of circ-ERBB2 was surveyed by bioinformatics analysis and dual-luciferase reporter and RNA immunoprecipitation (RIP) or RNA pulldown assays. We observed that circ-ERBB2 was overexpressed in TNBC, and TNBC patients with high circ-ERBB2 expression levels had a poor prognosis. Functionally, circ-ERBB2 knockdown constrained TNBC growth in vivo, reduced the Warburg effect, accelerated apoptosis, and repressed the proliferation, migration, and invasion of TNBC cells in vitro. Mechanically, circ-ERBB2 sponged microRNA 136-5p (miR-136-5p) to elevate pyruvate dehydrogenase kinase 4 (PDK4) expression. In conclusion, circ-ERBB2 facilitated the Warburg effect and malignancy of TNBC cells by the miR-136-5p/PDK4 pathway, at least in part. This study supports circ-ERBB2 as a prognostic indicator for TNBC.

Entities:  

Keywords:  PDK4; TNBC; circ-ERBB2; miR-136-5p; triple-negative breast cancer

Mesh:

Substances:

Year:  2021        PMID: 34370552      PMCID: PMC8462456          DOI: 10.1128/MCB.00609-20

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

Review 1.  Circular RNA: A new star of noncoding RNAs.

Authors:  Shibin Qu; Xisheng Yang; Xiaolei Li; Jianlin Wang; Yuan Gao; Runze Shang; Wei Sun; Kefeng Dou; Haimin Li
Journal:  Cancer Lett       Date:  2015-06-05       Impact factor: 8.679

Review 2.  Advances in the systemic treatment of triple-negative breast cancer.

Authors:  J M Lebert; R Lester; E Powell; M Seal; J McCarthy
Journal:  Curr Oncol       Date:  2018-06-13       Impact factor: 3.677

3.  Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing.

Authors:  Charissa Kim; Ruli Gao; Emi Sei; Rachel Brandt; Johan Hartman; Thomas Hatschek; Nicola Crosetto; Theodoros Foukakis; Nicholas E Navin
Journal:  Cell       Date:  2018-04-19       Impact factor: 41.582

Review 4.  The Warburg Effect: How Does it Benefit Cancer Cells?

Authors:  Maria V Liberti; Jason W Locasale
Journal:  Trends Biochem Sci       Date:  2016-01-05       Impact factor: 13.807

Review 5.  Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers.

Authors:  Nam Ho Jeoung
Journal:  Diabetes Metab J       Date:  2015-06       Impact factor: 5.376

6.  Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.

Authors:  Shujuan Sun; Jia Liu; Meisong Zhao; Yingyan Han; Pingbo Chen; Qingqing Mo; Beibei Wang; Gang Chen; Yong Fang; Yuan Tian; Jianfeng Zhou; Ding Ma; Qinglei Gao; Peng Wu
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

7.  LncRNA FOXP4-AS1 Is Involved in Cervical Cancer Progression via Regulating miR-136-5p/CBX4 Axis.

Authors:  Juan Zhao; Ting Yang; Long Li
Journal:  Onco Targets Ther       Date:  2020-03-19       Impact factor: 4.147

8.  Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.

Authors:  Shouhua Wang; Yongjie Zhang; Qiang Cai; Mingzhe Ma; Long Yang Jin; Mingzhe Weng; Di Zhou; Zhaohui Tang; Jian Dong Wang; Zhiwei Quan
Journal:  Mol Cancer       Date:  2019-10-17       Impact factor: 27.401

9.  Circular RNA circERBB2 promotes gallbladder cancer progression by regulating PA2G4-dependent rDNA transcription.

Authors:  Xince Huang; Min He; Shuai Huang; Ruirong Lin; Ming Zhan; Dong Yang; Hui Shen; Sunwang Xu; Wei Cheng; Jianxiu Yu; Zilong Qiu; Jian Wang
Journal:  Mol Cancer       Date:  2019-11-21       Impact factor: 27.401

View more
  3 in total

1.  Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitro.

Authors:  Meng Wang; Di Chen; Hanchao Zhang; Chengyu Luo
Journal:  Inflamm Res       Date:  2022-03-02       Impact factor: 4.575

Review 2.  Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.

Authors:  Zahra Foruzandeh; Davood Ghavi Dorabadi; Farzaneh Sadeghi; Fatemeh Zeinali-Sehrig; Mohammad Zaefizadeh; Yazdan Rahmati; Mohammad Reza Alivand
Journal:  Mol Biol Rep       Date:  2022-05-10       Impact factor: 2.742

Review 3.  Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer.

Authors:  Silvia Di Agostino; Mahrou Vahabi; Chiara Turco; Giulia Fontemaggi
Journal:  Noncoding RNA       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.